𝔖 Bobbio Scriptorium
✦   LIBER   ✦

KRAS mutation status is not predictive for objective response to anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancer

✍ Scribed by Stefan Boeck, Andreas Jung, Rüdiger P. Laubender…


Book ID
120914532
Publisher
Springer Japan
Year
2013
Tongue
English
Weight
195 KB
Volume
48
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES